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The transcription start sites of the human gene coding for the coagulation factor IX have been identified. Three major transcription initiation sites 
within a small area of _ 30 nucleotides were found by Sl nuclease analysis and primer extension studies. 
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1. INTRODUCTION 
Human coagulation factor IX (FIX) is a vitamin K- 
dependent glycoprotein that plays a key role in blood 
coagulation. It is a component of the middle phase of 
the intrinsic clotting pathway. In the activated form it 
interacts with factor VIIIa, phospholipids and calcium 
ions to form a complex that converts factor X to Xa 
Ill. 
The human FIX is encoded by a single functional 
gene which is located on the X-chromosome [2,3]. It 
contains 8 exons and 7 introns which cover a region of 
-34 kb [4]. The gene is expressed primarily in the liver 
[5]. Using primer extension and Sl nuclease mapping 
Anson et al. [4] detected 3 start sites of mRNA syn- 
thesis (Fig. 1). Two of these were considered to be an 
artefact while the transcription initiation site at an A 
(Fig. 1, position + 1) was pinpointed as the major start 
site. In contrast Salier et al. [6] recently claimed a ma- 
jor start site at position - 150. No transcription initia- 
tion was observed at the previous proposed site at 
position + 1. 
The discrepancy between both observations has ma- 
jor implications for the interpretation of past and 
future studies of the FIX gene promoter. For instance, 
mutations at positions -20, -6 and +13 [7-91 have 
been found in hemophilia B patients with an altered 
promoter function (hemophilia B Leyden). Further- 
more, mutation of position +13 results in the loss of 
liver specific transcription factor C/EBP binding [lo]. 
Therefore, we re-examined the site of transcription in- 
itiation of the FIX gene. Using primer extension ex- 
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periments and Sl nuclease mapping experiments on 
human liver RNA we identified 3 major transcription 
start sites at positions + 1, +4 and +30. No transcrip- 
tion start site was found at position - 150. 
2. MATERIALS AND METHODS 
2.1. Materials 
Reverse transcriptase and Sl nuclease were obtained from Phar- 
macia LKB Biotechnology Inc. and Bethesda Research Laboratories. 
[y-32P]dATP (>3000 Ci/mmol), [a-35S]dATP (>600 CVmmol) and 
T4-polynucleotide kinase were purchased from Amersham Interna- 
tional (Amersham, UK). The cDNA synthesis kit and RNasin were 
obtained from Promega Biotec (Madison, USA). Oligonucleotide 
primers were made on a Cyclone DNA synthesizer (Millipore, 
Bedford). 
2.2. RNA preparation 
Total RNA was extracted from human liver tissue, human lym- 
phocytes and HL60 cells as described previously [11,12]. 
2.3. Primer extension 
Primer extension was performed using 4 different oligonucleotide 
primers. The sequences in parentheses indicate the position of the 
primers in the complementary strand (numbering as in [13]). 
120 (5 ’ --82AAAGACCCATTGAGGGAGAT-63-3 ’ ) 
182 (5 ’ -+88TAGGATATCTACTCAGTCGT+‘07-3 ’ )
122 (5 - ’ +‘08GAATGTACAGTTTTTCTTGA+633s-3’) 
213 (5’-+6373AGGTATAATTCAGGTAAATTGG+63”-3’) 
90 ng of oligonucleotide primer (120/182/122/213) was labeled by 
T4-polynucleotide kinase and [y-32P]dATP. One tenth of the reaction 
was annealed with 50 pg total RNA for -16 h at 28°C in a 20 /tl mix- 
ture containing 40 mM Pipes (pH 6.4), 0.4 M NaCl, 1 mM EDTA 
(pH 8), 80% formamide. 
After hybridization the nucleic acids were’ recovered by ethanol 
precipitation. Thirty PI of a mixture containing 10 x first strand buf- 
fer (cDNA synthesis kit), 10 mM DTT, 1 mM each cold dNTP, 
4 mM sodium pyrophosphate, 20 U RNasin and 10 U reverse 
transcriptase was then added. After 1 h incubation at 42”C, the reac- 
tion was stopped by adding 1~10.5 M EDTA. The extended products 
were recovered by ethanol precipitation and suspended in 10~1 
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AGCCCACGAA ATCAGAGGTG 
-150 
TCACTTGTCC CAAGAGGCCA 
GATGGACATT ATTTCCCAGA 
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CMCTAATCG ACCTTiCCAC 
+1 
CGCGTGAGCA WTCAATOGC 
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AAATTTAATAATGACCACTG CCCATTCTCT -116 
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TTTCACAATCTGCTAGCAhAGGTTkCAG +35 
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September 1990 
Fig. 1. Nucleotide sequence of part of the human coagulation FIX gene locus (numbering as in [7]). The transcription initiation sites found in 
this study are indicated (*). Arrows indicate the position of the transcription initiation sites proposed by Anson et al. [4] and Salier et al. (61. 
Potential initiation codons are in bold type. 
formamide-dye solution (80% formamide, 10 mM EDTA (pH 8.0), 
1 mg/ml xylene cyan01 FF and 1 mg/ml bromophenol blue). The 
mixture was then boiled for 5 min and loaded onto a 8% denaturing 
polyacrylamide gel. The size of each extended product was compared 
with the dideoxynucleotide derived sequencing ladder obtained with 
the same primer. 
2.4. SI nuclease analysis 
Sl nuclease analysis with human liver RNA, human lymphocyte 
RNA and HL60 cell RNA was performed essentially as described by 
Maniatis et al. [12]. The “P-labeled fragments complementary to the 
mRNA were generated in a PCR reaction with 5 ‘-end labeled an- 
tisense primers and unlabeled sense primers. Sl nuclease mapping ex- 
periments were performed using two different sets of oligonucleotide 
primers. To generate probe A we employed the following 
oligonucleotides in our PCR amplification: primer 117 
(5 ‘--81AAGACCCATTGAGGGAGATG-62-3’) and primer 182 (see 
section 2.3: 5’-‘88TAGGATATCTACTCAGTGCTf’07-3’). 
To generate probe B we used the primers 203 (5’--‘p3CAGAC- 
TCAAATCAGCCACAG-‘74r3’) and 120 (see section 2.3: 
5’--82AAAGACCCATTGAGGGAGAT-63-3’). 
About l-2 x lo3 cpm of probe was dried down with 100 pg total 
RNA. The pellets were resuspended in a 20~1 mixture containing 
80% formamide, 40 mM Pipes (pH 6.4), 1 mM EDTA (pH 8.0), 
0.4 M NaCl. Samples were heated for 15 min at 85°C; then 
hybridization was performed for 16 h at 49°C. Three-hundred ,ul Sl 
nuclease buffer (0.28 M NaCl, 0.05 M sodium acetate (pH 4.5), 
4.5 mM ZnS04,20 pg/ml carrier ss DNA) were added to each sample 
and the reaction was started by the addition of 1000 U/ml Sl 
nuclease. After 30 min at 37°C the reaction was stopped by adding 
50 ~1 termination mix (4 M ammonium acetate and 100 mM EDTA). 
The RNA-DNA hybrids were recovered by phenol/chloroform ex- 
traction followed by ethanol precipitation and were analyzed on an 
8070 acrylamide-7 M urea sequencing el. The size of each protected 
fragment was compared with the dideoxynucleotide derived sequenc- 
ing ladder obtained with the same primer (182 or 120). 
3. RESULTS AND DISCUSSION 
To determine the site of transcription initiation of 
factor IX mRNA, both primer extension and Sl 
nuclease mapping were used. The 5 ‘-ends of FIX 
mRNAs were mapped by Sl protection of liver RNA, 
lymphocyte RNA and HL60 RNA. Each RNA sample 
was assayed with a Sl probe derived from the -81 to 
+108 region of FIX gene (probe A). The strategy for 
the mapping experiment is shown in Fig. 2A. The 
208 
results with probe A show a heterogeneous pattern of 
initiation, with 3 clusters of 5 ’ -ends in a 30 base region 
situated at position +l to +31 (Fig. 2B). This complex 
of 5 ‘-ends was absent when lymphocyte RNA or HL60 
RNA were used. Comparison with the dideox- 
ynucleotide derived sequencing ladder indicated that in 
the human FIX gene the 3 major initiation sites are 
located at positions + 1, +4 and +30. A minor single 
band was observed at position +8. 
To confirm that the Sl nuclease protected fragments 
represent ranscription initiation sites, primer extension 
experiments were performed. Synthetic 
oligonucleotides 182 (exon I), 122 (exon I-exon II 
splice) and 213 (exon II, not shown) were hybridized to 
RNA from human liver, human lymphocytes and HL60 
cells (Fig. 3A). Following reverse transcription and 
analysis on a denaturing gel, several major extended 
products were observed whose lengths corresponded to 
the transcription initiation sites + 1, +4 and +30 as 
determined by Sl nuclease analysis (Fig. 3B). One addi- 
tional stronger band at position +68 was found. This 
band, which does not correspond to the results of the 
Sl nuclease analysis, is probably an artefact. Finally a 
minor start site at position +8 was detected in both Sl 
nuclease mapping and primer extension analysis (Figs 2 
and 3). 
Our results indicate that major transcription initia- 
tion sites are situated at positions +l, +4 and +30 in 
the human FIX gene. The locations of the transcrip- 
tional start site clusters are comparable to those found 
previously [4]. However, there is a difference in the in- 
terpretation of the results. Anson et al. pinpointed only 
the start site at position +l as the major start site, 
whereas the other two start sites of mRNA synthesis 
were interpreted to be artefacts due to mRNA nicking. 
Since these two bands were also detected in our system 
both by Sl nuclease and primer extension experiments 
we conclude that they represent two true additional 
mRNA start points. 
We presume that the heterogeneity of the transcrip- 
tion initiation sites in the FIX gene is caused by the 
Volume 270, number 1,2 FEBS LETTERS 
2A 3A 
September I990 
Exon I 
6-t 
i 
tntron I 3’ 
-81 +I +Icl7 
$1 probe A '188bp 
2B 
gate 
123 456 
probe 
bP 
707 
zi!i 
77 
Fig. 2. Mapping the 5’-ends of human FIX mRNA. The segment of 
DNA used as probe (probe A) for Sl nuclease mapping is indicated 
(A). Primer extension analysis with oligonucleotide primer I82 is 
shown on the right. The same primer was used to generate probe A 
for Si m&ease mapping as described in section 2. Sl resistant 
fragments and primer extension products were analyzed on an 8% 
acrylamide-7 M urea gel. The DNA sequence shown in (B) was 
obtained with the primer 182. Sl nuclease mapping: lane 1, total 
human liver RNA; lane 2, HL60 RNA; lane 3, total human 
lymphocyte RNA, dideoxy GATC track. Primer extension reaction: 
lane 4, total human lymphocyte RNA, lane 5, total HL60 RNA, lane 
6, total human liver RNA. The length of protected fragments is 
indicated in bp. 
absence of a traditiona TATA box as observed in 
many other TATA box lacking genes fl4J. 
Experiments with a FIX chlor~phenicol 
acetyltransferase (CAT) chimeric gene suggested a ma- 
jor transcription initiation site at - 150 [6]. To confirm 
this transcription start site in vivo we have performed 
additional Sl n&ease experiments with probe B 
(described in section 2). No protected fra~ents were 
found in the upstream region between -193 and -63 
(results not shown). To confirm this result a primer ex- 
tension reaction was performed. For this purpose the 
synthetic primer 120 (-82 to -63) was used to 
specifically initiate reverse transcription of mRNA that 
starts at position - 150 (results not shown). This primer 
was also used to initiate Sanger’s dideoxy sequencing 
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Fig. 3. Identification of the transcriptional starts of the human FIX 
gene with two different primers. Ghgonucleotide primers 182 and 
122, as indicated in Fig. 3A, were hybri~z~ to RNA from human 
liver, lymphocytes and HL60 cells. The DNA sequence shown in (B) 
was obtained by priming a DNA clone of a human factor IX 
minigene in which the factor IX promoter is ligated to a full length 
cDNA (a gift from C. Schoemaker) with primer 182. Primer 
extension with primer 182: lane 1, liver RNA, lane 2, HL60 RNA; 
lane 3, lymphocyte RNA; dideoxy CTAG track. Primer extension 
with primer 122: lane 4, lymphocyte RNA; lane 5, HL60 RNA; lane 
6, liver RNA. The length of the extension products is indicated in bp. 
reaction. No extension products were found in this 
region, indicating that this site is more likely to be an 
artefact of the FIX-CAT chimeric system rather than a 
true transcription initiation site in vivo. 
In conclusion, our experiments identified in human 
liver 3 major transcription start sites at positions + 1, 
+4 and +30. This finding confirms the notion that the 
mutations in hemophilia B Leyden, that disrupt pro- 
moter function and ClEBP binding, are close to the 
transcriptional starts [7-lo]. In future promoter 
studies it may be best to take the transcription start sites 
into account and include at least the + 1 to +3 I region 
in expression vectors. 
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